Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: Record linkage cohort analyses

Journal of Epidemiology and Community Health

Volumn 66, Issue 12, 2012, Pages 1177-1181

  Wotton, Clare J ^a   Goldacre, Michael J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

COHORT ANALYSIS; DATA SET; DISEASE PREVALENCE; HEALTH RISK; IMMUNE SYSTEM; MORBIDITY; MORTALITY; RISK FACTOR; VIRAL DISEASE;

ADOLESCENT; ARTICLE; CHILD; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; MALE; MEDICAL RECORD; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO; STATISTICS; UNITED KINGDOM; VACCINATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENGLAND; FEMALE; HOSPITALIZATION; HUMANS; IMMUNE SYSTEM DISEASES; MALE; MEDICAL RECORD LINKAGE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; VACCINATION;

UNITED KINGDOM;

EID: 84872051138     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech-2011-200168     Document Type: Article

References (24)

1. Department of Health. Chapter 25. Pneumococcal. Immunisation Against Infectious Disease 2006-The Green Book. Department of Health, 2010. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/atdh/aten/documents/digitalasset/dh_122639.pdf (accessed 20 Jun 2011).
2. Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract 2009;59:e329-38.
3. Gluck T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clin Infect Dis 2008;46:1459-65.
4. Rahier JF, Moutschen M, Van Gompel A, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 2010;49:1815-27.
5. Langan SM, Hubbard R, Fleming K, et al. A population-based study of acute medical conditions associated with bullous pemphigoid. Br J Dermatol 2009;161:1149-52.
6. Goldacre M, Kurina L, Yeates D, et al. Use of large medical databases to study associations between diseases. QJM 2000;93:669-75.
7. Gill L, Goldacre M. English National Record Linkage of Hospital Episode Statistics and Death Registration Records. Oxford: Unit of Health-care Epidemiology, Oxford University, 2003.
8. Gill L, Goldacre M, Simmons H, et al. Computerised linking of medical records: methodological guidelines. J Epidemiol Community Health 1993;47:316-19.
9. Fois AF, Wotton CJ, Yeates D, et al. Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson's disease: record linkage studies. J Neurol Neurosurg Psychiatry 2010;81:215-21.
10. Ramagopalan SV, Wotton CJ, Handel AE, et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 2011;9:1.
11. Goldacre MJ, Wotton CJ, Yeates D, et al. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study. Eur J Gastroenterol Hepatol 2008;20:297-304.
12. Goldacre MJ, Wotton CJ, Yeates DG. Cancer and immune-mediated disease in people who have had meningococcal disease: record-linkage studies. Epidemiol Infect 2009;137:681-7.
13. Thomas HJ, Wotton CJ, Yeates D, et al. Pneumococcal infection in patients with coeliac disease. Eur J Gastroenterol Hepatol 2008;20:624-8.
14. Breslow NE, Day NE. Statistical Methods in Cancer Research, Volume II. The design and anlaysis of cohort studies. IARC Scientific Publication No. 82. Lyon: International Agency for Research in Cancer, 1987:103-15.
15. Doran MF, Crowson CS, Pond GR, et al. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287-93.
16. Pebody RG, Hippisley-Cox J, Harcourt S, et al. Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999e2005. Epidemiol Infect 2008;136:360-9.
17. Martin-Mola E, Balsa A. Infectious complications of biologic agents. Rheum Dis Clin North Am 2009;35:183-99.
18. Furst DE. The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum 2010;39:327-46.
19. Naz SM, Symmons DP. Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:871-83.
20. Zandman-Goddard G, Shoenfeld Y. Infections and SLE. Autoimmunity 2005;38:473-85.
21. Jess T, Winther KV, Munkholm P, et al. Mortality and causes of death in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. Gastroenterology 2002;122:1808-14.
22. Winther KV, Jess T, Langholz E, et al. Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology 2003;125:1576-82.
23. Naveau C, Houssiau FA. Pneumococcal sepsis in patients with systemic lupus erythematosus. Lupus 2005;14:903-6.
24. Foster KJ, Devitt N, Gallagher PJ, et al. Overwhelming pneumococcal septicaemia in a patient with ulcerative colitis and splenic atrophy. Gut 1982;23:630-2.